Ann Arbor, MI, March 13, 2018 – Strata Oncology, a precision oncology company, today announced that Aurora Health Care, the largest healthcare system in Wisconsin, and University of Texas Health Sciences at Houston (UTHealth) have joined the Strata Precision Oncology Network™ (Network). Formed in 2016 by Strata Oncology, the Network is accelerating precision oncology by providing advanced cancer patients routine access to tumor profiling and matching to a portfolio of biomarker-driven pharma-sponsored clinical trials, and has since expanded to 10 healthcare systems representing more than 85,000 new cancer patients annually,
“We are excited to join a collaborative group of leading cancer centers across the country working to ensure broad, timely patient access to precision medicine,” said Robert J. Amato, DO, Acting Director of the Division of Oncology at UTHealth McGovern Medical School and the Chief of the Division of Oncology at Memorial Hermann Cancer Center-TMC.
Members leverage theStrataNGS™ test, an 87-gene assay that sequences both DNA and RNA, as the foundation of comprehensive, integrated solution to deliver precision oncology system-wide. StrataNGS is available to all advanced solid tumor and lymphoma patients at no cost through the Strata Trial, a nationwide observational study providing tumor profiling and trial matching for 100,000 patients with advanced cancer.
Read full article here